News

Expect reported GRM at $6.5/bbl, Co’s EBITDA to improve QoQ & YoY due to better refining margins

Shares of SBI Cards and Payment Services Ltd. declined 5% on Monday, October 27, in response to its September quarter results, which came in below market expectations.

The company’s performance was impacted by higher operating expenses and lower interest income, though lower credit costs and strong growth expectations could lend support to sentiment going forward.

here

Mazagon Dock Shipbuilders, Larsen & Toubro, Indian Oil Corporation, IEX, Pidilite are a few among the 150-plus Nifty and broader market companies scheduled to report results this upcoming week.

here

Nearly 65% of the 43 analysts that have coverage on Kotak Mahindra Bank continue to recommend “buying” the stock after its September quarter results that were reported over the weekend. The stock is down up to 2.5% on Monday, October 27, in response to its quarterly results.

The results were largely in-line with expectations with marginal improvement in asset quality and a decline in profitability, both for the bank, and for most of its subsidiaries on a year-on-year basis.

here

Sudhir Singh, Coforge On CNBC-TV18

Q3 Is A Seasonally Weak Quarter But Will Stabilise In Q4FY26

Have Seen 14% EBIT Margin In  Q2 & Expect 14% In FY26

ESOP Cost Will Fall Which Is A Tailwind For Margin

FY26 Will Be A Robust Growth Year

We Are Very Close To Achieving $2 Bn Rev Run-Rate (Annualised)

FCF/PAT Guidance At 70-80% On An Ongoing Basis

Aim To Get The Free Cash Flow/PAT To 70-80% On An On Going Basis From Current 86%

There Are No Further AI & Data  Center Related Investments

14% EBIT Will The Minimum Threshold With Growth Being The Primary Imperative

Large Deal Wins At 10 In H1FY26 Vs 14 Last Year

Cigniti Tech shares are up 5.7% at the moment.

Its net profit rose 25% sequentially to ₹83 crore for the quarter ended September 30, 2025, compared with ₹66 crore in the previous quarter.

Revenue from operations grew 7% quarter-on-quarter to ₹577 crore, suggesting moderate topline expansion.

here

Supreme Petro shares are down 3.7% at the moment.

The petrochemicals company reported a net profit of ₹148 crore for Q2 FY26, up 63% year-on-year from ₹91 crore. Revenue for the quarter declined 55% to ₹1,117 crore compared with ₹2,519 crore in the same period last year. The company’s EBITDA stood at ₹78.7 crore, down 59.6% from ₹194 crore in Q2 FY25. EBITDA margin was at 7%, slightly lower than 7.7% in the year-ago period.

Zen Tech down over 5% in opening hour of trade on Q2 results impact

Coforge shares are up 5% after reporting their second quarter earnings.

It reported a net profit of ₹375.8 crore for the September quarter (Q2 FY26), rising 18.4% sequentially from ₹317.4 crore. The figure surpassed CNBC-TV18’s estimate of ₹357 crore.

Revenue for the quarter stood at ₹3,985.7 crore, up 8% quarter-on-quarter from ₹3,688.6 crore, though slightly below the poll estimate of ₹4,075 crore. In dollar terms, revenue came in at $462 million, compared with $442 million in Q1, while analysts had projected $469 million.

here

Overweight rating, target price Rs 2,500

Co Needed To Deliver On Margins & Cash Flows After The Challenges Last Time

Co Did Exactly That With Margin At 14% Beating Consensus/JPM Expectations By 30 bps/50 bps

Revenues Grew 5.9% CC QoQ & Came Broadly In-Line With Expectations

While Deal TCV Continued To Remain At >$500mn For The Fifth Consecutive Quarter

FCF Turned Positive With FCF/PAT of 86%, Above Its Target Band Of 75-80%

Mgmt Highlighted Demand Has Improved Somewhat

Mgmt Expects H2 Growth To Be Robust On The Back Of Strong Deal Wins And Pipeline

Mgmt Continues To Target 14% EBIT Margins For FY26

Buy Call, Target `1,475/sh

In-line Q2 Revenue While EBITDA/Adjusted Pat Beat Consensus By 2%/8%

Gross/Reported EBITDA Margin Contracted 492/175 bps YoY

Margin Decline On Anticipated Price Erosion In Revlimid As Well As Competition In Some Pdts

Excluding Lenalidomide, Co’s EBITDA Margin Works Out To 19–20%

Co Was Able To Maintain A Margin Of Approx 25% For Quarter Owing To A Cut In R&D Spending

Q3FY26 Expected To Be A Weak-Margin Quarter

All Attention Is Now On Fate Of Semaglutide Filling In Canada

Nearly 65% of the 43 analysts that have coverage on Kotak Mahindra Bank continue to recommend “buying” the stock after its September quarter results that were reported over the weekend.

The results were largely in-line with expectations with marginal improvement in asset quality and a decline in profitability, both for the bank, and for most of its subsidiaries on a year-on-year basis.

here

The Hyderabad-based drug major reported a net profit of ₹1,347 crore for the September quarter (Q2 FY26), up 7.3% year-on-year from ₹1,256 crore, though slightly below the CNBC-TV18 poll estimate of ₹1,403.7 crore. The company’s revenue increased 9.8% YoY to ₹8,828 crore, compared with ₹8,038 crore in the same period last year, surpassing the poll estimate of ₹8,595.4 crore.

Kotak Mahindra Bank’s net interest income grew by 4% from last year to ₹7,311 crore, while its net profit saw a drop of 3% from the year-ago period to ₹3,253 crore. Advances grew by nearly 16% from last year, while deposit growth stood at 14.6%. Asset quality saw a marginal improvement from the previous quarter, provisions were down on a sequential basis, while Net Interest Margins (NIMs) declined by 11 basis points from last year. The management said during its earnings call that it has completed its due diligence to acquire the government’s stake in IDBI Bank.

Welcome to CNBC-TV18’s LIVE Blog on Q2 Earnings. Check this space for LIVE Updates on  the Q2 results, previews, management commentary, guidance, stock reactions and more.NewsLive TVMarketPopular CategoriesCalculatorsTrending NowLet's Connect with CNBCTV 18Network 18 Group :©TV18 Broadcast Limited. All rights reserved.